AN ARTICLE ON NASH IN NEWSWEEK !

newspaper-1075797 1920


Have a look on the following article published the 30th of January 1016  


NASH IS THE 21ST CENTURY’S LOOMING PUBLIC HEALTH THREAT

BY  ON 1/30/16 AT 2:50 PM


This article present the NASH and its public health consequences. This time, the noticed compagnies are pertinents except for Sanofi not yet in NASH but just interested in that metabolic disorder :


«  Because no treatment or cure exists for NASH, more than a dozen pharmaceutical and biotech companies are in a race to put the first drug on the market. Although large companies like Gilead, Bristol-Myers and Sanofi are involved, the boutique groups Intercept and Genfit lead the pack with Phase III trials scheduled to start this year. The payoff could be massive: Analysts predict that the market for a NASH drug could reach $35 billion or more by 2025. » 


The two leaders in NASH treatment are clearly listed : INTERCEPT and GENFIT.

I am still very doubious about the future of INTERCEPT in NASH  

the market size is proposed again .. 35 B$ in 2025  …. 

Now, you just have to evaluate the ratio Benefit/Risk by yourself before investing in a biotech targeting NASH !!!










Share on StockTwits

WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE